Gastrointestinal Manifestations of Cystic Fibrosis

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2016 Jun 23

PMID 27330503

Citations 25

Authors

Sabina Sabharwal

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis has historically been considered a pulmonary disease, but with the increasing life expectancy of these patients, gastrointestinal manifestations are becoming more important. Furthermore, nutritional status is closely linked to pulmonary function and, thus, overall mortality. This article discusses gastrointestinal manifestations (which involve nutritional, pancreatic, hepatobiliary, and, in particular, gastrointestinal tract issues) of cystic fibrosis as well as management of the disease. In addition, the article discusses studies that have been critical to our understanding of gastrointestinal manifestations of cystic fibrosis.

Citing Articles

How Do Early Weight Trajectories Explain Social Inequalities in Lung Function in Children With Cystic Fibrosis?: A Longitudinal Interventional Disparity Effects Analysis With Time-varying Mediators and Intermediate Confounders.

Schluter D, Keogh R, Daniel R, Agbla S, Taylor-Robinson D Epidemiology. 2025; 36(2):275-285.

PMID: 39760864 PMC: 11774196. DOI: 10.1097/EDE.0000000000001826.

Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.

Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R World J Clin Pediatr. 2024; 13(2):93341.

PMID: 38948001 PMC: 11212754. DOI: 10.5409/wjcp.v13.i2.93341.

Ocular Changes in Cystic Fibrosis: A Review.

Liberski S, Confalonieri F, Cofta S, Petrovski G, Kociecki J Int J Mol Sci. 2024; 25(12).

PMID: 38928397 PMC: 11203677. DOI: 10.3390/ijms25126692.

Functional Consequences of CFTR Interactions in Cystic Fibrosis.

Ramananda Y, Naren A, Arora K Int J Mol Sci. 2024; 25(6).

PMID: 38542363 PMC: 10970640. DOI: 10.3390/ijms25063384.

Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D) (Pre-D trial) in adults with....

Sivapiromrat A, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt W Contemp Clin Trials Commun. 2024; 38:101278.

PMID: 38435430 PMC: 10904905. DOI: 10.1016/j.conctc.2024.101278.

References

Maisonneuve P, FitzSimmons S, Neglia J, Campbell 3rd P, Lowenfels A . Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst. 2003; 95(5):381-7. DOI: 10.1093/jnci/95.5.381. View

Colombo C, Ellemunter H, Houwen R, Munck A, Taylor C, Wilschanski M . Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros. 2011; 10 Suppl 2:S24-8. DOI: 10.1016/S1569-1993(11)60005-2. View

Stark L, Opipari-Arrigan L, Quittner A, Bean J, Powers S . The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF. Pediatr Pulmonol. 2010; 46(1):31-5. PMC: 4410776. DOI: 10.1002/ppul.21322. View

Sheikh S, Ryan-Wenger N, McCoy K . Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol. 2012; 48(6):556-62. DOI: 10.1002/ppul.22630. View

Paccou J, Zeboulon N, Combescure C, Gossec L, Cortet B . The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int. 2009; 86(1):1-7. DOI: 10.1007/s00223-009-9316-9. View

Stallings V, Stark L, Robinson K, Feranchak A, Quinton H . Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008; 108(5):832-9. DOI: 10.1016/j.jada.2008.02.020. View

Luder E, Kattan M, Thornton J, Koehler K, Bonforte R . Efficacy of a nonrestricted fat diet in patients with cystic fibrosis. Am J Dis Child. 1989; 143(4):458-64. DOI: 10.1001/archpedi.1989.02150160084017. View

Peterson M, Jacobs Jr D, Milla C . Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003; 112(3 Pt 1):588-92. DOI: 10.1542/peds.112.3.588. View

Borowitz D, Baker R, Stallings V . Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002; 35(3):246-59. DOI: 10.1097/00005176-200209000-00004. View

10.

Brady M, Rickard K, Yu P, Eigen H . Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc. 1992; 92(7):813-7. View

11.

Neglia J, FitzSimmons S, Maisonneuve P, Schoni M, Schoni-Affolter F, Corey M . The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995; 332(8):494-9. DOI: 10.1056/NEJM199502233320803. View

12.

Houwen R, van der Doef H, Sermet I, Munck A, Hauser B, Walkowiak J . Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr. 2009; 50(1):38-42. DOI: 10.1097/MPG.0b013e3181a6e01d. View

13.

Werlin S, Benuri-Silbiger I, Kerem E, Adler S, Goldin E, Zimmerman J . Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010; 51(3):304-8. DOI: 10.1097/MPG.0b013e3181d1b013. View

14.

Aldamiz-Echevarria L, Prieto J, Andrade F, Elorz J, Sojo A, Lage S . Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy. Pediatr Res. 2009; 66(5):585-9. DOI: 10.1203/PDR.0b013e3181b4e8d3. View

15.

LLOYD-STILL J, Smith A, WESSEL H . Fat intake is low in cystic fibrosis despite unrestricted dietary practices. JPEN J Parenter Enteral Nutr. 1989; 13(3):296-8. DOI: 10.1177/0148607189013003296. View

16.

Powers S, Jones J, Ferguson K, Piazza-Waggoner C, Daines C, Acton J . Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis. Pediatrics. 2005; 116(6):1442-50. DOI: 10.1542/peds.2004-2823. View

17.

Steinkamp G, Wiedemann B . Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax. 2002; 57(7):596-601. PMC: 1746376. DOI: 10.1136/thorax.57.7.596. View

18.

Heijerman H, Lamers C, Bakker W . Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med. 1991; 114(3):200-1. DOI: 10.7326/0003-4819-114-3-200. View

19.

Sokol R, Durie P . Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr. 1999; 28 Suppl 1:S1-13. DOI: 10.1097/00005176-199900001-00001. View

20.

Van Biervliet S, Devos M, Delhaye T, Van Biervliet J, Robberecht E, Christophe A . Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids. 2008; 78(2):109-15. DOI: 10.1016/j.plefa.2007.12.005. View